Global Partnership in Biopharmaceutics and Translational Medicine
CBA 18th Annual Conference
Saturday, June 15th, 2013
University of Maryland Shady Grove Conference Center
9600 Gudelsky Dr, Rockville, MD 20850
The Chinese Biopharmaceutical Association, USA (CBA) will host the 18th Annual Conference at the University of Maryland Shady Grove Conference Center on Saturday, June 15th, 2013. The theme of this year’s conference is “Global Partnership in Biopharmaceutics and Translational Medicine;” it will address the critical importance of establishing worldwide collaboration to capture the great opportunity for the advancement of modern medicine and biopharmaceuticals.
The Conference includes five sessions:
• Drug Discovery: New Strategies and Platforms
• Translational Genomics and anti-cancer therapy
• Opportunities in New high tech parks in China
• Regulatory Compliances in Biopharmaceuticals
• Collaborative Opportunities and Partnership for U.S.-China Biopharmaceuticals.
The 18th Annual Conference will bring together the elite minds from the biopharmaceutical industry, regulatory agencies and academia from around the world to share their insights on the latest development of biopharmaceutics and translational medicine. The conference provides a perfect venue for the attendees to meet and network with high-caliber speakers, high-level industry leaders and high-profile governmental officials from both China and the US, to explore potential partnership and collaboration opportunities. The Conference also offers exhibition spots for interested companies to promote their technology and products.
In addition to a compelling conference program, CBA will present its 2013 Brilliant Achievement Award at the Conference, recognizing individuals of exemplary accomplishments in promoting collaboration and global development involving the biopharmaceutical sector in China. We anticipate more than 500 attendees to participate in the 18th Annual Conference.
The BioCapital Tour
In conjunction with the 18th Annual Conference, CBA will host, with co-sponsorship from the State of Maryland and Montgomery County, a “Bio-Capital Tour” on June 13th - 14th, 2013. This event is of great benefit and interest to many Chinese pharmaceutical companies who would love to learn the latest FDA guidelines on biosimilars and diagnostics, and visit the campus of FDA, US Pharmacopeia, AstraZeneca's R&D Center & GMP bioreactor facility for commercial products, world-class biomedical research centers at NIH and University of Maryland Schools of Medicine and Dentistry, as well as and many other attractions that only Maryland can offer as a national leader in promoting biotechnology and the headquarter of the BioCapital. The tour will be open to platinum sponsors and above ($5000 and above). If interested, please contact Dr. Ping Chen at email@example.com to register.
“Business Partnering” Session
High-profile venture investors and officials from high-tech parks in China will also join the 18th CBA Annual Conference to discuss funding and collaboration opportunities. A special “Business Partnering” session on June 16th will be arranged to set up face-to-face partnering meetings between the Chinese delegations and the interested high-caliber oversea talents and project leaders of bio/med R&D projects with leading-edge technology. So far, Beijing CFLD Group, Jiangsu Nanjing New Town Science Park, Sichuan Meishan Biopharmaceutical Science Park, and Guangzhou Hi-Tech Park, etc, have confirmed to join the “Business Partnering” session and more Chinese delegations have expressed interests to participate also. CBA is now calling for “Business Partnering” participants and bio/med R&D projects. If interested, please contact Dr. Dazhi Lai at firstname.lastname@example.org. Please make sure you choose the option of "Business Partnering Meeting" when you fill in the online registration form at here.